Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin, Taxanes, and Trastuzumab

Study Questions:

Can early biomarkers predict future cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab?